Expression of integrin alpha10 is induced in malignant melanoma

Cellular Oncology

Volumn 29, Issue 5, 2007, Pages 373-386

  Wenke, Ann Kathrin ^a   Kjellman, Christian ^b   Lundgren Akerlund, Evy ^b   Uhlmann, Christian ^a   Haass, Nikolas K ^c   Herlyn, Meenhard ^c   Bosserhoff, Anja K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Cartela AB   (Sweden)

^c WISTAR INSTITUTE   (United States)

Author keywords

AP 2; Cancer; Ets 1; Integrin; Malignant melanoma; Melanocytes; Migration

Indexed keywords

ALPHA INTEGRIN; ANTIBODY; INTEGRIN ALPHA 10; INTEGRIN ALPHA 10 ANTIBODY; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL CLONE; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING CELL; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MELANOCYTE; MELANOMA; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; UPREGULATION; WILD TYPE;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CLONE CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA CHAINS; MELANOCYTES; MELANOMA; NEOPLASM INVASIVENESS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 34547898804     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. S.M. Albelda, S.A. Mette, D.E. Elder, R. Stewart, L. Damjanovich, M. Herlyn and C.A. Buck, Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression, Cancer Res. 50 (1990), 6757-6764.
2. S. Aznavoorian, M.L. Stracke, J. Parsons, J. McClanahan and L.A. Liotta, Integrin alphavbeta3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways, J. Biol. Chem. 271 (1996), 3247-3254.
3. A. Baldi, D. Santini, T. Battista, E. Dragonetti, G. Ferranti, T. Petitti, A.M. Groeger, A. Angelini, R. Rossiello, F. Baldi, P.G. Natali and M.G. Paggi, Expression of AP-2 transcription factor and of its downstream target genes c-kit, E-cadherin and p21 in human cutaneous melanoma, J. Cell Biochem. 83 (2001), 364-372.
4. M. Bar-Eli, Role of AP-2 in tumor growth and metastasis of human melanoma, Cancer Metastasis Rev. 18 (1999), 377-385.
5. T. Bengtsson, A. Aszodi, C. Nicolae, E.B. Hunziker, E. Lundgren-Akerlund and R. Fassler, Loss of alpha10beta1 integrin expression leads to moderate dysfunction of growth plate chondrocytes, J. Cell Sci. 118 (2005), 929-936.
6. L. Camper, U. Hellman and E. Lundgren-Akerlund, Isolation, cloning, and sequence analysis of the integrin subunit alpha10, a beta1-associated collagen binding integrin expressed on chondrocytes, J. Biol. Chem. 273 (1998), 20383-20389.
7. L. Camper, K. Holmvall, C. Wangnerud, A. Aszodi and E. Lundgren-Akerlund, Distribution of the collagen-binding integrin alpha10beta1 during mouse development, Cell Tissue Res. 306 (2001), 107-116.
8. E.H. Danen, T.J. de Vries, R. Morandini, G.G. Ghanem, D.J. Ruiter and G.N. van Muijen, E-cadherin expression in human melanoma, Melanoma Res. 6 (1996), 127-131.
9. E.H. Danen, K.F. Jansen, A.A. Van Kraats, I.M. Cornelissen, D.J. Ruiter and G.N. van Muijen, Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice, Int. J. Cancer 61 (1995), 491-496.
10. E.H. Danen, P.J. Ten Berge, G.N. van Muijen, A.E. Van 't Hof-Grootenboer, E.B. Brocker and D.J. Ruiter, Emergence of alpha 5 beta 1 fibronectin- and alpha v beta 3 vitronectin-receptor expression in melanocytic tumour progression, Histopathology 24 (1994), 249-256.
11. J. Dittmer, The biology of the Ets1 proto-oncogene, Mol. Cancer 2 (2003), 29.
12. S.R. Elshaw, K. Sisley, N. Cross, A.K. Murray, S.M. MacNeil, M. Wagner, C.E. Nichols and I.G. Rennie, A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins, Br. J. Ophthalmol. 85 (2001), 732-738.
13. J. Gille and R.A. Swerlick, Integrins: role in cell adhesion and communication, Ann. NY Acad. Sci. 797 (1996), 93-106.
14. R.H. Goldbrunner, H.K. Haugland, C.E. Klein, S. Kerkau, K. Roosen and J.C. Tonn, ECM dependent and integrin mediated tumor cell migration of human glioma and melanoma cell lines under serum-free conditions, Anticancer Res. 16 (1996), 3679-3687.
15. J.C. Hahne, A.F. Okuducu, A. Kaminski, A. Florin, F. Soncin and N. Wernert, Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth, Oncogene 24 (2005), 5384-5388.
16. C. Hellerbrand, E. Bumes, F. Bataille, W. Dietmaier, R. Massoumi and A.K. Bosserhoff, Reduced expression of CYLD in human colon and hepatocellular carcinomas, Carcinogenesis 28(1) (2006), 21-27.
17. M. Herlyn and I.M. Shih, Interactions of melanocytes and melanoma cells with the microenvironment, Pigment Cell Res. 7 (1994), 81-88.
18. T.J. Hieken, S.G. Ronan, M. Farolan, A.L. Shilkaitis and T.K. Das Gupta, Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma, Anticancer Res. 16 (1996), 2321-2324.
19. M.Y. Hsu, D. Elder and M. Herlyn, Melanoma: The Wistar (WM) melanoma cell lines, 3 (1999), 259-274.
20. M.Y. Hsu, D.T. Shih, F.E. Meier, P. Van Belle, J.Y. Hsu, D.E. Elder, C.A. Buck and M. Herlyn, Adenoviral gene transfer of beta3 integrin subunit induces conversion from radial to vertical growth phase in primary human melanoma, Am. J. Pathol. 153 (1998), 1435-1442.
21. S. Huang, D. Jean, M. Luca, M.A. Tainsky and M. Bar-Eli, Loss of AP-2 results in downregulation of c-KIT and enhancement of melanoma tumorigenicity and metastasis, EMBO J. 17 (1998), 4358-4369.
22. M.J. Humphries, Integrin activation: the link between ligand binding and signal transduction, Curr. Opin. Cell Biol. 8 (1996), 632-640.
23. M.J. Humphries, Integrin structure, Biochem. Soc. Trans. 28 (2000), 311-339.
24. D. Jean, J.E. Gershenwald, S. Huang, M. Luca, M.J. Hudson, M.A. Tainsky and M. Bar-Eli, Loss of AP-2 results in upregulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells, J. Biol. Chem. 273 (1998), 16501-16508.
25. J.M. Karjalainen, J.K. Kellokoski, M.J. Eskelinen, E.M. Alhava and V.M. Kosma, Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma, J. Clin. Oncol. 16 (1998), 3584-3591.
26. S. Kuphal, R. Bauer and A.K. Bosserhoff, Integrin signaling in malignant melanoma, Cancer Metastasis Rev. 24 (2005), 195-222.
27. S. Kuphal, H.G. Palm, I. Poser and A.K. Bosserhoff, Snailregulated genes in malignant melanoma, Melanoma Res. 15 (2005), 305-313.
28. S. Kuphal, I. Poser, C. Jobin, C. Hellerbrand and A.K. Bosserhoff, Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma, Oncogene 23 (2004), 8509-8519.
29. D. Leprince, A. Gegonne, J. Coll, C. de Taisne, A. Schneeberger, C. Lagrou and D. Stehelin, A putative second cellderived oncogene of the avian leukaemia retrovirus E26, Nature 306 (1983), 395-397.
30. J.F. Marshall, D.C. Rutherford, L. Happerfield, A. Hanby, A.C. McCartney, J. Newton-Bishop and I.R. Hart, Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas, Br. J. Cancer 77 (1998), 522-529.
31. T. Nakano, M. Abe, K. Tanaka, R. Shineha, S. Satomi and Y. Sato, Angiogenesis inhibition by transdominant mutant Ets-1, J. Cell. Physiol. 184 (2000), 255-262.
32. J. Nikkola, P. Vihinen, T. Vlaykova, M. Hahka-Kemppinen, J. Heino and S. Pyrhonen, Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma, Melanoma Res. 14 (2004), 29-37.
33. N. Oda, M. Abe and Y. Sato, ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3, J. Cell. Physiol. 178 (1999), 121-132.
34. Y. Ohnishi, S. Tajima and A. Ishibashi, Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells, Eur. J. Dermatol. 11 (2001), 420-423.
35. I. Poser and A.K. Bosserhoff, Transcription factors involved in development and progression of malignant melanoma, Histol. Histopathol. 19 (2004), 173-188.
36. A. Pourtier-Manzanedo, C. Vercamer, E. Van Belle, V. Mattot, F. Mouquet and B. Vandenbunder, Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model, Oncogene 22 (2003), 1795-1806.
37. T. Rothhammer, J.C. Hahne, A. Florin, I. Poser, F. Soncin, N. Wernert and A.K. Bosserhoff, The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma, Cell Mol. Life Sci. 61 (2004), 118-128.
38. T. Rothhammer, I. Poser, F. Soncin, F. Bataille, M. Moser and A.K. Bosserhoff, Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration, Cancer Res. 65 (2005), 448-456.
39. D. Ruiter, T. Bogenrieder, D. Elder and M. Herlyn, Melanomastroma interactions: structural and functional aspects, Lancet Oncol. 3 (2002), 35-43.
40. Y. Sato, K. Teruyama, T. Nakano, N. Oda, M. Abe, K. Tanaka and C. Iwasaka-Yagi, Role of transcription factors in angiogenesis: Ets-1 promotes angiogenesis as well as endothelial apoptosis, Ann. NY Acad. Sci. 947 (2001), 117-123.
41. R. Silye, A.J. Karayiannakis, K.N. Syrigos, S. Poole, S. van Noorden, W. Batchelor, H. Regele, W. Sega, H. Boesmueller, T. Krausz and M. Pignatelli, E-cadherin/catenin complex in benign and malignant melanocytic lesions, J. Pathol. 186 (1998), 350-355.
42. S.A. Tahtakran and M.A. Selleck, Ets-1 expression is associated with cranial neural crest migration and vasculogenesis in the chick embryo, Gene Expr. Patterns. 3 (2003), 455-458.
43. Y. Takada, T. Kamata, A. Irie, W. Puzon-McLaughlin and X.P. Zhang, Structural basis of integrin-mediated signal transduction, Matrix Biol. 16 (1997), 143-151.
44. D.K. Watson, M.J. McWilliams, P. Lapis, J.A. Lautenberger, C.W. Schweinfest and T.S. Papas, Mammalian ets-1 and ets-2 genes encode highly conserved proteins, Proc. Natl. Acad. Sci. USA 85 (1988), 7862-7866.
45. A.K. Wenke, T. Rothhammer, M. Moser and A.K. Bosserhoff, Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2å and Ets-1, Biochem. Biophys. Res. Comm. 345 (2006), 495-501.
46. N. Wernert, A. Stanjek, S. Kiriakidis, A. Hugel, H.C. Jha, R.Mazitschek and A. Giannis, Inhibition of Angiogenesis In Vivo by ets-1 Antisense Oligonucleotides-Inhibition of Ets-1 Transcription Factor Expression by the Antibiotic Fumagillin, Angew. Chem. Int. Edit. Engl. 38 (1999), 3228-3231.